Advanced Adjuvants for Novel Vaccines: Expanding Access to Technology in the Fight Against Infectious Disease

This fact sheet describes the positive impact that adjuvants can have on vaccine efficacy and, potentially, immunization program costs. It also describes PATH’s work to expand global access to proprietary and non-proprietary adjuvants as well as relevant formulations technologies to facilitate their successful exploration and use by product development partnerships and developing-country vaccine manufacturers.

Publication date: June 2012

Advanced Adjuvants for Novel Vaccines

708.6 KB PDF
View Resource